Rigel Pharmaceuticals, Inc. logo

Rigel Pharmaceuticals, Inc. (RIGL)

Market Closed
16 Dec, 21:00
NASDAQ (NGS) NASDAQ (NGS)
$
42. 02
-0.46
-1.08%
$
909.44M Market Cap
- P/E Ratio
0% Div Yield
319,560 Volume
-0.06 Eps
$ 42.48
Previous Close
Day Range
41 42.49
Year Range
14.63 52.24
Want to track RIGL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 76 days
Name Time Cons. EPS Eps
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
3 Mar 2026 (In 2 months)
1.08
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
6 Nov 2025
0.93
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
5 Nov 2025
0.94
1.46
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
4 Nov 2025
0.93
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
5 Aug 2025
1.42
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
5 May 2025
0.09
0.63
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
3 Mar 2025
-
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
5 Nov 2024
0.06
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
30 Jul 2024
-
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
30 Apr 2024
-
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
5 Mar 2024
-
0
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
1 Nov 2023
-
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
1 Nov 2016
-
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
2 Aug 2016
-
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
3 May 2016
-
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
8 Mar 2016
-
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
3 Nov 2015
-
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
4 Aug 2015
-
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
7 May 2015
-
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
3 Mar 2015
-
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
4 Nov 2014
-
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
5 Aug 2014
-
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
7 May 2014
-
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
4 Mar 2014
-
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
5 Nov 2013
-
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
6 Aug 2013
-
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
7 May 2013
-
-
Rigel Pharmaceuticals, Inc. logo
RIGL Rigel Pharmaceuticals, Inc.
5 Mar 2013
-
-

RIGL Earnings Reports FAQ

What is the earnings per share (EPS) for RIGL?

The current EPS is -0.06.

What is the company's earnings growth rate?

Over the past 12 years, the earnings growth rate has been approximately 34,661.9%, reflecting the RIGL's performance and NASDAQ (NGS) market conditions.

When is the next earnings release date?

The next earnings release is expected to be on 2026-03-03, based on the RIGL's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings were 1.46 per share, reported on 2025-11-05. For dividend history, visit the RIGL Dividends page.

What is the price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio is 28.78, calculated based on the most recent stock price of $42.02.